A comprehensive invited review published today in Brain Medicine confronts one of the most persistent paradoxes in modern medicine: psychiatry remains the only major clinical discipline that diagnoses ...

The Joint Entrance Examination (JEE) Main 2026 is one of the most competitive engineering entrance exams in India, conducted by the National Testing Agency (NTA) for admission to top engineering ...

Cambridge researchers map the convergence of biomarkers, digital phenotyping, and AI toward biologically grounded ...

The peer-reviewed invited review in Brain Medicine titled "New approaches to enhance the diagnosis of psychiatric disorders," is freely available via Open Access, starting on 10 March 2026 in Brain ...

Welcome, everybody, to Ascom's 2025 Full Year Results Conference, and also welcome to the participants that we have on the webcast. Our plan for today according to the agenda, which maybe is going to ...

Fabien Deshayes discusses the strategies behind Monzo’s Developer Velocity squad. He explains the "Platform as a Product" mindset, emphasizing the need for engineers with product acumen and tenure. He ...

To some, METR’s “time horizon plot” indicates that AI utopia—or apocalypse—is close at hand. The truth is more complicated. MIT Technology Review Explains: Let our writers untangle the complex, messy ...

Suchandrima Bhowmik has written over 300 articles on various health conditions, medical news, and recent breakthroughs. Her work appears in several publications, including Medical News Today, ...

Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...

The complement system is an innate immune response that leads to increased inflammation. The drug pegcetacoplan—a complement inhibitor—was approved for medical use in the United States in 2021 to ...

Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...